Senior Staff Physician/ Clinical Assistant Professor
Oncology
Dr. Clara Hwang, MD
|
|
Give Review
Clara Hwang works in the field of Oncology. She attended University of Michigan Medical School. She over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Clara Hwang is a published doctor and has 15 publications published. The lastest was: 'Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer.' She is registered with Medicare and accepts Medicare payments.
Publications
- Reply to g. Procopio et Al.
- Chemotherapeutic inhibitors in the treatment of prostate cancer.
- KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings.
- Overcoming docetaxel resistance in prostate cancer: a perspective review.
- Averaged differential expression for the discovery of biomarkers in the blood of patients with prostate cancer.
- Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM.
- Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.
- Androgen ablation augments human HLA2.1-restricted T cell responses to PSA self-antigen in transgenic mice.
- Cytoprotective effects of IAPs revealed by a small molecule antagonist.
- EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor.
- Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
- Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells.
- Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer.
- Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen.
Schools
Univ Of Mi Med Sch
Doctors Specialties
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Michigan Hospitals and Health Centers -
University of Michigan Medical School
Hospital
-
Henry Ford Hospital
Drug Facts
| NPI NUMBER | 1407978505 | |
| NPPES Provider LastName | HWANG | |
| NPPES Provider FirstName | CLARA | |
| NPPES Provider ZIPCode | 482022608 | |
| NPPES Provider State | MI | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 858.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 137.0 | |
| Percent Opioid Claims | 15.97 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1407978505 |
| Last Name Of The Provider | HWANG |
| First Name Of The Provider | CLARA |
| View All |
Similar Doctors
|
Dr. Anthony F. Shields, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Irina Y. Dobrosotskaya, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John F. Ensley, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jasdeepa Nagi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shirish M. Gadgeel, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sayeh M. Lavasani, MD
This Doctor is OpenDoctor Recommended.
|